SCHEMBL19737752

SCHEMBL19737752

Nc1c(C(=O)Nc2ccncc2)sc2nc(-c3ccncc3)ccc12

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 18/20 0.85
TP53 P04637 7/20 0.85
THRB P10828 2/20 0.85
TDP1 Q9NUW8 1/20 0.85
SMN1; SMN2 Q16637 5/20 0.76
POLB P06746 5/20 0.71
ROCK2 O75116 1/20 0.71
ROCK1 Q13464 1/20 0.71
CLK4 Q9HAZ1 1/20 0.71
MEN1 O00255 6/20 0.71
KMT2A Q03164 6/20 0.71
MCL1 Q07820 3/20 0.71
NPC1 O15118 2/20 0.71
PKM P14618 1/20 0.71
RXFP1 Q9HBX9 5/20 0.59
KDM4E B2RXH2 3/20 0.58
ALDH1A1 P00352 3/20 0.58
LMNA P02545 3/20 0.58
USP2 O75604 2/20 0.58
ALOX15 P16050 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11887886 0.92 MAPT (0.80) MAPTTP53THRBTDP1SMN1; SMN2
SCHEMBL11887868 0.92 MAPT (0.80) MAPTTP53THRBTDP1SMN1; SMN2
SCHEMBL14954942 0.92 MAPT (1.00) MAPTTP53THRBTDP1SMN1; SMN2
SCHEMBL19737751 0.91 MAPT (0.72) MAPTTP53THRBTDP1SMN1; SMN2
SCHEMBL14954959 0.90 MAPT (0.79) MAPTTP53THRBTDP1SMN1; SMN2
SCHEMBL19737573 0.90 MAPT (0.88) MAPTTP53THRBTDP1SMN1; SMN2
SCHEMBL11887885 0.89 MAPT (0.74) MAPTTP53THRBTDP1SMN1; SMN2
SCHEMBL11887847 0.87 MAPT (1.00) MAPTTP53THRBTDP1SMN1; SMN2
SCHEMBL14955022 0.87 MAPT (1.00) MAPTTP53THRBTDP1SMN1; SMN2
SCHEMBL11887981 0.86 MAPT (0.77) MAPTTP53THRBTDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10689394-B2 Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof THE UNIVERSITY OF TOKYO (JP) 2020-06-23 US claimed
US-20190177336-A1 THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF THE UNIVERSITY OF TOKYO (JP) 2019-06-13 US claimed
US-10689394-B2 Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof THE UNIVERSITY OF TOKYO (JP) 2020-06-23 US disclosed
US-10689394-B2 Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof THE UNIVERSITY OF TOKYO (JP) 2020-06-23 US disclosed
US-20190177336-A1 THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF THE UNIVERSITY OF TOKYO (JP) 2019-06-13 US disclosed
US-20190177336-A1 THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF THE UNIVERSITY OF TOKYO (JP) 2019-06-13 US disclosed
WO-2017217439-A1 THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF 国立大学法人東京大学 2017-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10689394-B2 Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof BRD4, DRD4, TH MAPT 3704/4885TP53 4111/4885THRB 387/4885
US-20190177336-A1 THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF DERL1, UBQLN1, ADRM1 MAPT 882/4885TP53 708/4885THRB 3593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.